이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Betaine Addition to Water Loading Prior to Running Exercise

2026년 9월 18일 업데이트: Emilia Zawieja, Poznan University of Life Sciences

Effects of a Betaine-Supplemented Hydration Protocol on Sweat Rate and Exercise Performance in Runners

This randomized, double-blind, placebo-controlled crossover study will investigate whether acute betaine ingestion as part of a pre-exercise hyperhydration strategy improves endurance running performance and influences hydration-related responses during prolonged exercise.

Approximately 30 recreationally trained male and premenopausal female runners will complete two experimental trials: a betaine condition and a placebo/control condition. In the betaine condition, participants will ingest anhydrous betaine at a dose of 0.07 g/kg body mass as part of a standardized pre-exercise hydration protocol providing a total fluid intake of approximately 25 mL/kg body mass.

Following the hydration protocol, participants will complete 60 minutes of treadmill running at 60% of the running velocity corresponding to VO₂max, followed by a 5-minute recovery period and a 5-km treadmill time trial.

The primary outcome will be 5-km running time-trial performance. Secondary outcomes will include exercise-induced fluid and sweat loss, urinary hydration markers, sweat electrolyte concentrations, physiological responses, exercise economy, substrate utilization, blood lactate concentration, perceived exertion, thirst, and thermal sensation.

연구 개요

상태

아직 모집하지 않음

정황

연구 유형

중재적

등록 (추정된)

20

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인)

건강한 자원 봉사자를 받아들입니다

예

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Age 18-45 years
  • Sex: men and premenopausal women
  • Continuous running training for at least 12 months
  • At least 3 running training sessions per week
  • Willingness and ability to complete the treadmill exercise protocol: 60 minutes of running at 60% of the running velocity corresponding to VO₂max, followed by a 5-km running time trial
  • Medical clearance for participation in maximal and prolonged exercise testing

Exclusion Criteria:

  • Age <18 or >45 years
  • Postmenopausal women
  • Use of betaine, choline, folic acid/folate, or vitamin B12 supplements within 3 months prior to study participation
  • Current musculoskeletal injury or injury occurring within the previous 2 months
  • Uncontrolled arterial hypertension
  • Pregnancy or breastfeeding
  • Diabetes requiring insulin therapy or inadequately controlled diabetes
  • Active or severe liver disease, including ALT or AST >3× the upper limit of normal
  • Renal impairment, including eGFR <60 mL/min/1.73 m²
  • Untreated or unstable thyroid disease, including hypothyroidism or hyperthyroidism
  • Gastrointestinal disease that may affect nutrient absorption
  • Kidney disease, cardiovascular disease, irritable bowel syndrome, or adrenal disease
  • Use of diuretics, SGLT2 inhibitors, laxatives, or glucocorticoids
  • Any medical contraindication to physical exercise and/or failure to obtain medical clearance for exercise testing
  • Elevated body temperature at the time of testing
  • Cystic fibrosis

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 다른
  • 할당: 무작위
  • 중재 모델: 크로스오버 할당
  • 마스킹: 삼루타

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Betaine → Placebo Sequence

Participants will first complete the betaine-enriched hyperhydration condition. After the washout period, they will complete the placebo hyperhydration condition.

Anhydrous betaine (trimethylglycine) will be administered as a single dose of 0.07 g/kg body mass, dissolved in a commercially available sports drink (5 mL/kg body mass), 150 minutes before exercise. The betaine-containing drink will constitute the first bolus of a standardized pre-exercise hyperhydration protocol providing a total fluid intake of approximately 25 mL/kg body mass over 120 minutes.

Participants will receive the same commercially available sports drink (5 mL/kg body mass) without added betaine 150 minutes before exercise. This will be followed by four additional fluid boluses of mineral water (5 mL/kg each) administered at 120, 90, 60, and 30 minutes before exercise, for a total pre-exercise fluid intake of approximately 25 mL/kg body mass.

실험적: Placebo → Betaine Sequence

Participants will first complete the placebo hyperhydration condition. After the washout period, they will complete the betaine-enriched hyperhydration condition.

Anhydrous betaine (trimethylglycine) will be administered as a single dose of 0.07 g/kg body mass, dissolved in a commercially available sports drink (5 mL/kg body mass), 150 minutes before exercise. The betaine-containing drink will constitute the first bolus of a standardized pre-exercise hyperhydration protocol providing a total fluid intake of approximately 25 mL/kg body mass over 120 minutes.

Participants will receive the same commercially available sports drink (5 mL/kg body mass) without added betaine 150 minutes before exercise. This will be followed by four additional fluid boluses of mineral water (5 mL/kg each) administered at 120, 90, 60, and 30 minutes before exercise, for a total pre-exercise fluid intake of approximately 25 mL/kg body mass.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
5-km Running Time-Trial Performance
기간: During the 5-km treadmill time trial performed after the 60-minute running preload and a 5-minute recovery period in each experimental trial.

Time required to complete a 5-km treadmill running time trial, expressed in seconds. Participants will be instructed to complete the distance as quickly as possible and will be allowed to adjust treadmill speed throughout the trial. Lower completion time indicates better performance.

During the 5-km treadmill time trial performed after the 60-minute running preload and a 5-minute recovery period in each experimental trial.

2차 결과 측정

결과 측정
측정값 설명
기간
Sweat rate
기간: From immediately before the 60-minute running preload to completion of the subsequent 5-km time trial during each experimental trial.

Whole-body sweat rate will be estimated from the change in body mass from immediately before exercise to completion of the 5-km time trial, adjusted for fluid intake and urine output, if applicable, and expressed as L/h. Body mass will be measured using the calibrated electronic scale integrated with the BOD POD system (COSMED, Italy) and expressed in kilograms (kg). Changes in body mass will also be calculated and reported as a percentage of pre-exercise body mass (%).

From immediately before the 60-minute running preload to completion of the subsequent 5-km time trial during each experimental trial.

기타 결과 측정

결과 측정
측정값 설명
기간
Sweat sodium concentration
기간: Between minutes 30 and 60 of the 60-minute running preload during each experimental trial.

Sodium concentration will be measured in sweat samples collected from standardized sites on the forearm and thigh during exercise. Sweat samples will be collected between minutes 30 and 60 of the 60-minute running preload. Sodium concentration will be analyzed using a HORIBA ion-selective electrode analyzer and reported in mmol/L.

Between minutes 30 and 60 of the 60-minute running preload during each experimental trial.
Sweat Potassium Concentration
기간: Between minutes 30 and 60 of the 60-minute running preload during each experimental trial.

Potassium concentration will be measured in sweat samples collected from standardized sites on the forearm and thigh during exercise. Sweat samples will be collected between minutes 30 and 60 of the 60-minute running preload. Sweat potassium concentration will be analyzed using a HORIBA ion-selective electrode analyzer and reported in mmol/L.

Between minutes 30 and 60 of the 60-minute running preload during each experimental trial.
Blood lactate concentration
기간: Immediately after the 60-minute running preload and immediately after the 5-km time trial during each experimental trial.

Blood lactate concentration will be measured using a portable Lactate Scout 4 analyzer. Measurements will be obtained immediately after completion of the 60-minute running preload and immediately after completion of the subsequent 5-km time trial. Blood lactate concentration will be reported in mmol/L.

Immediately after the 60-minute running preload and immediately after the 5-km time trial during each experimental trial.
Heart rate
기간: Continuously during the 60-minute running preload and the subsequent 5-km time trial in each experimental trial.

Heart rate will be monitored continuously using a Garmin chest-strap heart rate monitor with integrated electrodes throughout the 60-minute running preload and the subsequent 5-km time trial. Outcome variables will include mean heart rate during the 60-minute preload, mean heart rate during the 5-km time trial, and maximal heart rate achieved during the 5-km time trial. Heart rate will be reported in beats per minute (bpm).

Continuously during the 60-minute running preload and the subsequent 5-km time trial in each experimental trial.
Core Body Temperature
기간: Continuously during the 60-minute running preload and the subsequent 5-km time trial in each experimental trial.

Core body temperature will be monitored continuously using a CORE body temperature sensor attached to the Garmin chest strap throughout the 60-minute running preload and the subsequent 5-km time trial. Outcome variables will include mean core body temperature during the exercise protocol and the highest core body temperature recorded during the exercise protocol. Temperature will be reported in degrees Celsius (°C).

Continuously during the 60-minute running preload and the subsequent 5-km time trial in each experimental trial.
Running Economy
기간: During the final 10 minutes (minutes 50-60) of the 60-minute running preload in each experimental trial.

Running economy will be assessed by breath-by-breath indirect calorimetry using a QUARK RMR metabolic system during the final 10 minutes (minutes 50-60) of the 60-minute running preload. Running economy will be quantified as mean oxygen consumption (VO₂) relative to body mass at the standardized running velocity and expressed as mL·kg-¹·min-¹. Lower oxygen consumption at the same running velocity indicates better running economy.

During the final 10 minutes (minutes 50-60) of the 60-minute running preload in each experimental trial.
Respiratory Exchange Ratio
기간: During the final 10 minutes (minutes 50-60) of the 60-minute running preload in each experimental trial.

Respiratory exchange ratio (RER) will be assessed by breath-by-breath indirect calorimetry using a QUARK RMR metabolic system during the final 10 minutes (minutes 50-60) of the 60-minute running preload. RER will be calculated as the ratio of carbon dioxide production (VCO₂) to oxygen consumption (VO₂) and expressed as a unitless value. The mean RER over the measurement period will be used for analysis.

During the final 10 minutes (minutes 50-60) of the 60-minute running preload in each experimental trial.
Urine specific gravity
기간: Immediately before the 60-minute running preload and immediately after completion of the 5-km time trial in each experimental trial.

Urine specific gravity (USG) will be measured using a URIT-31 urine analyzer from urine samples collected immediately before the 60-minute running preload and after completion of the subsequent 5-km time trial. USG will be reported as a dimensionless value. Urine osmolality will also be estimated from USG using a predefined conversion equation and reported in mOsm/kg.

Immediately before the 60-minute running preload and immediately after completion of the 5-km time trial in each experimental trial.
Rating of Perceived Exertion (RPE)
기간: At minutes 30, and 60 of the 60-minute running preload and immediately after completion of the 5-km time trial during each experimental trial.

Rating of perceived exertion will be assessed using the Borg 6-20 Rating of Perceived Exertion scale, ranging from 6 ("no exertion at all") to 20 ("maximal exertion"). RPE will be recorded at 15-minute intervals during the 60-minute running preload and immediately after completion of the 5-km time trial.

At minutes 30, and 60 of the 60-minute running preload and immediately after completion of the 5-km time trial during each experimental trial.
Thirst Sensation
기간: Immediately before the 60-minute running preload, at minutes 30,and 60 of the preload, and immediately after completion of the 5-km time trial during each experimental trial.

Perceived thirst will be assessed using a 9-point categorical thirst sensation scale ranging from 1 ("not thirsty at all") to 9 ("very, very thirsty"). Participants will be asked to rate their current sensation of thirst at each measurement time point.

Immediately before the 60-minute running preload, at minutes 30,and 60 of the preload, and immediately after completion of the 5-km time trial during each experimental trial.
Thermal Sensation
기간: Immediately before the 60-minute running preload, at minutes 30 and 60 of the preload, and immediately after completion of the 5-km time trial during each experimental trial.

Thermal sensation will be assessed using a 17-point thermal sensation scale ranging from 0 to 8 in 0.5-point increments, with 0 representing "unbearably cold", 4 representing "neutral", and 8 representing "unbearably hot". Participants will rate their whole-body thermal sensation at each measurement time point.

Immediately before the 60-minute running preload, at minutes 30 and 60 of the preload, and immediately after completion of the 5-km time trial during each experimental trial.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 10월 1일

기본 완료 (추정된)

2027년 5월 31일

연구 완료 (추정된)

2027년 12월 30일

연구 등록 날짜

최초 제출

2026년 9월 18일

QC 기준을 충족하는 최초 제출

2026년 9월 18일

처음 게시됨 (실제)

2026년 9월 25일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 25일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 18일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

추가 관련 MeSH 약관

기타 연구 ID 번호

  • BETxSWEAT

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

미정

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다